Oaktree Acquisition Corp. III Life Sciences (OACC) Current Assets (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences has reported Current Assets for 3 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 4.47% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 4.47% YoY), and the FY2025 full-year result was $1.5 million, down 0.65% from the prior year.
• Current Assets for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
• The five-year high for Current Assets was $1.6 million in Q2 2025, with the low at $1.4 million in Q1 2026.
• Historically, Current Assets has averaged $1.5 million across 3 years, with a median of $1.5 million in 2025.
• Annual changes were most pronounced in 2025 — Current Assets declined 0.65% — and 2026, when it retreated 4.47%.
• Oaktree Acquisition Corp. III Life Sciences' Current Assets stood at $1.6 million in 2024, then dropped by 0.65% to $1.5 million in 2025, then slipped by 8.53% to $1.4 million in 2026.
• The last three Current Assets figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.